🇮🇹 Poteligeo in Italy

Poteligeo (MOGAMULIZUMAB) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Poteligeo
  • Status: approved

Poteligeo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Italy

Frequently asked questions

Is Poteligeo approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for Poteligeo in Italy?

Kyowa Kirin is the originator. The local marketing authorisation holder may differ — check the official source linked above.